{
  "story_id": "d904454e7bd974424ee7a6d1f16d6ff1",
  "desk": "drm3",
  "revision": 1,
  "published_at": "2026-09-02T16:25:28.000Z",
  "content_hash": "13cb30fb506a398468c8386155cd9c01eaa7f4e33d7b43708609e78f565d8a3d",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "MIT Researchers Map Brain's Striatum to Aid Drug Development",
    "dek": "MIT scientists created a new atlas of the striatum's neurons to identify targets for treating Huntington's disease and addiction.",
    "prose": "Researchers at MIT generated a new atlas of the striatum, identifying 31 distinct subgroups of neurons based on the genes they express using single-cell RNA sequencing. [^1]\n\nBryan Roth, one of the inventors of chemogenetics, said at the BRAIN Initiative conference on 2026-08-13 that he had identified seven ongoing clinical trials of chemogenetics in China. [^2]\n\nMyriam Heiman, the Picower Professor of Neuroscience at MIT, stated that the atlas serves as a foundation for future studies on Huntington's disease and opioid use disorder. [^3]\n\nThe research found that dorsal populations of medium spiny neurons express higher levels of the genes MSH2 and MSH3, which increase the number of CAG repeats in the huntingtin gene associated with Huntington's disease. [^4]\n\nThe study identified two specific 'outlier' populations of medium spiny neurons, known as D1 and D2 outliers, which are involved in addiction, depression, and schizophrenia. [^5]\n\nChemogenetics works by engineering neurons to express designer receptors (DREADDs) that can be activated by normally inert drugs, allowing specific brain cells to be excited or inhibited. [^6]\n\nThe seven clinical trials that Bryan Roth identified in China are targeting pain, Parkinson's disease, and epilepsy. [^7]",
    "cited": "[{\"statement\":\"Researchers at MIT generated a new atlas of the striatum, identifying 31 distinct subgroups of neurons based on the genes they express using single-cell RNA sequencing.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T15:00:13.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]},{\"statement\":\"Bryan Roth, one of the inventors of chemogenetics, said at the BRAIN Initiative conference on 2026-08-13 that he had identified seven ongoing clinical trials of chemogenetics in China.\",\"source\":\"The NeuroAI archive\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T16:25:28.000Z\",\"publisher_count\":1,\"sources\":[\"The NeuroAI archive\"]},{\"statement\":\"Myriam Heiman, the Picower Professor of Neuroscience at MIT, stated that the atlas serves as a foundation for future studies on Huntington's disease and opioid use disorder.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T15:00:13.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]},{\"statement\":\"The research found that dorsal populations of medium spiny neurons express higher levels of the genes MSH2 and MSH3, which increase the number of CAG repeats in the huntingtin gene associated with Huntington's disease.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T15:00:13.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]},{\"statement\":\"The study identified two specific 'outlier' populations of medium spiny neurons, known as D1 and D2 outliers, which are involved in addiction, depression, and schizophrenia.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T15:00:13.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]},{\"statement\":\"Chemogenetics works by engineering neurons to express designer receptors (DREADDs) that can be activated by normally inert drugs, allowing specific brain cells to be excited or inhibited.\",\"source\":\"The NeuroAI archive\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T16:25:28.000Z\",\"publisher_count\":1,\"sources\":[\"The NeuroAI archive\"]},{\"statement\":\"The seven clinical trials that Bryan Roth identified in China are targeting pain, Parkinson's disease, and epilepsy.\",\"source\":\"The NeuroAI archive\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-02T16:25:28.000Z\",\"publisher_count\":1,\"sources\":[\"The NeuroAI archive\"]}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": null,
  "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "2bb76416bfe4f17aff7a631d3c7c1a69",
      "thread_id": "aa2195ea58eced72e9b9088af40e96ff",
      "thread_label": "Clozapine",
      "novelty": "UPDATE",
      "content_hash": "64fc3454aa7b62c95bf49b8aed990fb8431d83851506e6de69c0e30005cb72ea",
      "last_published_at": "2026-09-02T16:25:28.000Z",
      "read_receipt": {
        "slice_hash": "4cacbcc1c8ccf43a891d2f2aaa9dd85a75a21f0eb716714b606b48e8aa0d2073",
        "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDJUMTY6MDA6MTIuMDAwMDAwWiIsImlkIjoiM2Q3MWZkM2JlOTQyY2I5ZWNkN2NiMWQxNDk3YTg3NjMiLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDJUMTY6NDk6NDEuMDAwMDAwWiIsImlkIjoiYTVlNGY3ZjRmZWRlZTBiZTA5ODllYmY0YWFhMThmMjIiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 100,
        "window_days": 3,
        "bytes_scanned": 10113494,
        "credits": 8,
        "price_per_100_rows": 8,
        "sig": "BXDkUoytkUF-6vhEBXL_iYp0NHuO6YAIj2XKODfENdK_O4bUpfgaHF894DBgK6LO9dEThXKDng75CTuAHrNvDA",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      }
    },
    "written_at": "2026-09-03T00:41:19.827Z"
  },
  "cited_facts": [
    {
      "statement": "Researchers at MIT generated a new atlas of the striatum, identifying 31 distinct subgroups of neurons based on the genes they express using single-cell RNA sequencing.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-01T15:00:13.000Z",
      "publisher_count": 1,
      "sources": [
        "Medical Xpress"
      ]
    },
    {
      "statement": "Bryan Roth, one of the inventors of chemogenetics, said at the BRAIN Initiative conference on 2026-08-13 that he had identified seven ongoing clinical trials of chemogenetics in China.",
      "source": "The NeuroAI archive",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T16:25:28.000Z",
      "publisher_count": 1,
      "sources": [
        "The NeuroAI archive"
      ]
    },
    {
      "statement": "Myriam Heiman, the Picower Professor of Neuroscience at MIT, stated that the atlas serves as a foundation for future studies on Huntington's disease and opioid use disorder.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-01T15:00:13.000Z",
      "publisher_count": 1,
      "sources": [
        "Medical Xpress"
      ]
    },
    {
      "statement": "The research found that dorsal populations of medium spiny neurons express higher levels of the genes MSH2 and MSH3, which increase the number of CAG repeats in the huntingtin gene associated with Huntington's disease.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-01T15:00:13.000Z",
      "publisher_count": 1,
      "sources": [
        "Medical Xpress"
      ]
    },
    {
      "statement": "The study identified two specific 'outlier' populations of medium spiny neurons, known as D1 and D2 outliers, which are involved in addiction, depression, and schizophrenia.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-01T15:00:13.000Z",
      "publisher_count": 1,
      "sources": [
        "Medical Xpress"
      ]
    },
    {
      "statement": "Chemogenetics works by engineering neurons to express designer receptors (DREADDs) that can be activated by normally inert drugs, allowing specific brain cells to be excited or inhibited.",
      "source": "The NeuroAI archive",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T16:25:28.000Z",
      "publisher_count": 1,
      "sources": [
        "The NeuroAI archive"
      ]
    },
    {
      "statement": "The seven clinical trials that Bryan Roth identified in China are targeting pain, Parkinson's disease, and epilepsy.",
      "source": "The NeuroAI archive",
      "instrument": "News",
      "claim_key": null,
      "published_at": "2026-09-02T16:25:28.000Z",
      "publisher_count": 1,
      "sources": [
        "The NeuroAI archive"
      ]
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true."
}